Robust antibody response after a third BNT162b2 vaccine compared to the second among immunocompromised and healthy individuals, a prospective longitudinal cohort study.
Shapiro Ben David S, Mizrahi B, Rahamim-Cohen D, Supino-Rosin L, Shahar A, Hermoni-Alon S, Fremder Sacerdote A, Irony A, Lazar R, Kalkstein N, Lustig Y, Indenbaum V, Landsberger D, Mizrahi-Reuveni M, Shapira S.
Shapiro Ben David S, et al. Among authors: mizrahi b.
Vaccine. 2022 Jun 26;40(30):4038-4045. doi: 10.1016/j.vaccine.2022.05.051. Epub 2022 May 28.
Vaccine. 2022.
PMID: 35641358
Free PMC article.